Literature DB >> 1706325

Direct sequence evaluation of the major outer membrane protein gene variant regions of Chlamydia trachomatis subtypes D', I', and L2'.

D Dean1, M Patton, R S Stephens.   

Abstract

The nucleotide sequences of variable segments (VS) 1, 2, and 4 for the major outer membrane protein gene (omp1) of Chlamydia trachomatis were determined for serologically defined subtypes D', I', and L2'. Asymmetric DNA amplification was used to produce single-stranded DNA for direct sequencing. Amino acid substitutions were detected in VS1, VS2, and VS4 for I', in VS2 for L2', and in VS4 for D'. DNA sequencing of omp1 variant regions may be an important method for evaluating the molecular epidemiology of Chlamydia spp.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1706325      PMCID: PMC257882          DOI: 10.1128/iai.59.4.1579-1582.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Trachoma vaccine studies on Taiwan.

Authors:  J T GRAYSTON; R L WOOLRIDGE; S WANG
Journal:  Ann N Y Acad Sci       Date:  1962-03-05       Impact factor: 5.691

2.  Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes.

Authors:  W Baehr; Y X Zhang; T Joseph; H Su; F E Nano; K D Everett; H D Caldwell
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

3.  Epitope mapping with solid-phase peptides: identification of type-, subspecies-, species- and genus-reactive antibody binding domains on the major outer membrane protein of Chlamydia trachomatis.

Authors:  J W Conlan; I N Clarke; M E Ward
Journal:  Mol Microbiol       Date:  1988-09       Impact factor: 3.501

4.  Nucleotide and deduced amino acid sequences for the four variable domains of the major outer membrane proteins of the 15 Chlamydia trachomatis serovars.

Authors:  Y Yuan; Y X Zhang; N G Watkins; H D Caldwell
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

5.  Why we need a program for the control of Chlamydia trachomatis.

Authors:  J Schachter
Journal:  N Engl J Med       Date:  1989-03-23       Impact factor: 91.245

6.  Trachoma vaccine studies in monkeys.

Authors:  S P Wang; J T Grayston; E R Alexander
Journal:  Am J Ophthalmol       Date:  1967-05       Impact factor: 5.258

7.  Diversity of Chlamydia trachomatis major outer membrane protein genes.

Authors:  R S Stephens; R Sanchez-Pescador; E A Wagar; C Inouye; M S Urdea
Journal:  J Bacteriol       Date:  1987-09       Impact factor: 3.490

8.  Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis.

Authors:  Y X Zhang; S Stewart; T Joseph; H R Taylor; H D Caldwell
Journal:  J Immunol       Date:  1987-01-15       Impact factor: 5.422

9.  In vitro neutralization of Chlamydia trachomatis with monoclonal antibody to an epitope on the major outer membrane protein.

Authors:  R Peeling; I W Maclean; R C Brunham
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

10.  High-resolution mapping of serovar-specific and common antigenic determinants of the major outer membrane protein of Chlamydia trachomatis.

Authors:  R S Stephens; E A Wagar; G K Schoolnik
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

View more
  21 in total

1.  What more is there to learn about trachoma?

Authors:  M Melese; W Alemayehu; B Gaynor; E Yi; J P Whitcher; T M Lietman
Journal:  Br J Ophthalmol       Date:  2003-05       Impact factor: 4.638

2.  Species-, serogroup-, and serovar-specific epitopes are juxtaposed in variable sequence region 4 of the major outer membrane proteins of some Chlamydia trachomatis serovars.

Authors:  B E Batteiger; P M Lin; R B Jones; B J Van Der Pol
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Molecular and mutation trends analyses of omp1 alleles for serovar E of Chlamydia trachomatis. Implications for the immunopathogenesis of disease.

Authors:  D Dean; K Millman
Journal:  J Clin Invest       Date:  1997-02-01       Impact factor: 14.808

4.  Serotyping and genotyping of genital Chlamydia trachomatis isolates reveal variants of serovars Ba, G, and J as confirmed by omp1 nucleotide sequence analysis.

Authors:  S A Morré; J M Ossewaarde; J Lan; G J van Doornum; J M Walboomers; D M MacLaren; C J Meijer; A J van den Brule
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

5.  Typing of Chlamydia trachomatis strains from urine samples by amplification and sequencing the major outer membrane protein gene (omp1).

Authors:  C I Bandea; K Kubota; T M Brown; P H Kilmarx; V Bhullar; S Yanpaisarn; P Chaisilwattana; W Siriwasin; C M Black
Journal:  Sex Transm Infect       Date:  2001-12       Impact factor: 3.519

Review 6.  Emancipating Chlamydia: Advances in the Genetic Manipulation of a Recalcitrant Intracellular Pathogen.

Authors:  Robert J Bastidas; Raphael H Valdivia
Journal:  Microbiol Mol Biol Rev       Date:  2016-03-30       Impact factor: 11.056

7.  Chlamydia trachomatis serovar differentiation by direct sequence analysis of the variable segment 4 region of the major outer membrane protein gene.

Authors:  E Poole; I Lamont
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

8.  Similarity of Chlamydia pneumoniae strains in the variable domain IV region of the major outer membrane protein gene.

Authors:  C A Gaydos; T C Quinn; L D Bobo; J J Eiden
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

9.  Direct detection and genotyping of Chlamydia trachomatis in cervical scrapes by using polymerase chain reaction and restriction fragment length polymorphism analysis.

Authors:  J Lan; J M Walboomers; R Roosendaal; G J van Doornum; D M MacLaren; C J Meijer; A J van den Brule
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

Review 10.  Vaccines for bacterial sexually transmitted infections: a realistic goal?

Authors:  P F Sparling; C Elkins; P B Wyrick; M S Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.